Abstract

BackgroundCOVID-19 disease has had a profound impact worldwide since it was discovered in Wuhan, China, in December 2019. Laboratory testing is crucial to prompt identification of positive cases, initiation of treatment and management strategies. However, medical scientists are vulnerable to infection due to the risk of exposure in the laboratory and the community. This study sought to determine the awareness of laboratory safety measures, assess the personal efforts of medical scientists in creating a safe laboratory environment for testing and examine the laboratory safety enabling factors.MethodsThe data used for the study were generated among medical scientists in Nigeria through an internet-broadcasted questionnaire and were analyzed using IBM SPSS Statistics (version 25).ResultsThe majority of the respondents had a high awareness of laboratory safety measures (60.3%) and demonstrated good personal efforts in creating a safe laboratory testing environment (63%). The level of awareness of laboratory safety measures was significantly associated with respondents’ level of education (χ2 = 6.143; p = 0.046) and influences respondents’ efforts in creating a safe laboratory testing environment (p = 0.007). However, just a few respondents could convincingly attest to the availability of adequate and appropriate PPE with proper utilization training (45.1%), adequate rest and other welfare packages (45.8%) as well as access to appropriate Biological Safety Cabinets (BSCs) and other essential equipment in their laboratories (48.8%). Furthermore, a significant association existed between the availability of laboratory safety enabling factors and respondents’ efforts in creating a safe environment for testing with the p-value ranging between < 0.0001 and 0.003.ConclusionThis study revealed that despite the high awareness of safety measures and good personal efforts of the study participants in creating a safe laboratory-testing environment, there was poor availability of safety facilities, equipment, support and welfare packages required to enhance their safety. It is, therefore, crucial to provide necessary laboratory biosafety equipment and PPE in order not to compromise medical scientists’ safety as they perform their duties in COVID-19 pandemic response.

Highlights

  • COVID-19 disease has had a profound impact worldwide since it was discovered in Wuhan, China, in December 2019

  • Laboratory safety enabling factors This study revealed that most respondents opined that safety enabling factors such as sufficiently trained medical scientists (58%), reviewed, updated protocols and working practice policies (74%), training and awareness plans, as well as Standard Operating Procedure (SOP) (74.1%) were available in their laboratories

  • Just a few respondents could convincingly attest to the availability of adequate and appropriate protective equipment (PPE) with proper utilization training (45.1%), adequate rest and other welfare packages (45.8%), as well as access to appropriate Biological Safety Cabinets (BSCs) and other essential equipment in their workplaces (48.8%). (Table 4)

Read more

Summary

Introduction

COVID-19 disease has had a profound impact worldwide since it was discovered in Wuhan, China, in December 2019. Laboratory testing is crucial to prompt identification of positive cases, initiation of treatment and management strategies. Medical scientists are vulnerable to infection due to the risk of exposure in the lab‐ oratory and the community. Since the turn of the third decade in the new millennium, the COVID-19 pandemic has been ravaging the world, after it was first discovered in Wuhan. Central and pertinent to these responses are the roles that the medical scientists play as part of the multidisciplinary healthcare team in ensuring reliable, accurate and timely diagnosis, monitoring of positive patients, therapeutic drug monitoring/surveillance, confirmation of recovery, validation of testing protocols, invention and development of novel vaccines. Reports showed that most of the COVID19 patients require regular laboratory testing to ensure adequate staging, prognosis, therapeutic monitoring and epidemiological surveillance [3]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call